Can i mix humalog and lantus

When the container is full, seal the lid before placing it in the trash. Don't share. Even if you change the needle, sharing an insulin pen or syringe may spread diseases carried in the blood, including hepatitis and HIV.

Avoid mix-ups. If you use more than one type of insulin, make each vial or pen look different by putting a rubber band around one type of insulin. Check your medicine. Humalog can be confused with NovoLog or Humulin other insulins. When you pick up your insulin at the pharmacy, be sure it's the right type of insulin. Treat low blood sugar hypoglycemia. Carry a quick source of sugar, such as glucose tablets, candy, or juice, to treat low blood sugar. Signs of low blood sugar are listed on the other side of the page.

Test your blood sugar level. Ask your doctor how often you should test your blood sugar level. Keep a log of your blood sugar levels and how much insulin you take each day. Bring the log with you each time you visit your doctor. Get a periodic lab test. You should have a hemoglobin A1c test at least twice a year to determine how well your diabetes is being controlled. The test shows an average of your blood sugar control over a 6- to week period.

Call for illness or changes in habits. Your insulin needs may change because of illness, stress, changes in eating habits or physical activity, and other medicines you take. Call your doctor if you experience these conditions. Never change your insulin dose unless advised by your doctor.

Rapid-acting insulin; begins working in 15 to 30 minutes and lasts for 5 hours or less. Treatment of type 1 and type 2 diabetes mellitus to improve control of blood glucose. Humalog should be injected under the skin within 15 minutes before or immediately after a meal. The frequency and dose of insulin are unique to each individual Daily doses of insulin are based upon body weight, diet, activity level, age, individual sensitivity to insulin, type of diabetes 1 or 2 Multiple daily doses according to blood glucose levels are typical.

See safety tip 2 to determine if Humalog can be mixed with another insulin before injection Ask your doctor, nurse, or pharmacist to show you how to draw your dose of insulin into a syringe and inject it, select the dose on a pen device and inject the insulin, or use an insulin pump Before injecting a dose, take the chill off refrigerated insulin by gently rolling the vial, pen, or cartridge between the palm of both hands do not shake the insulin vigorously Using a syringe or insulin pen, inject the insulin below the skin not in the muscle in the upper thighs, upper arms, buttocks, or abdomen; the site of the injection should be changed rotated with each dose Don't use Humalog if the insulin appears cloudy instead of clear and colorless.

Talk to your doctor about managing your diabetes during pregnancy and breastfeeding. Hypoglycemia low blood sugar ; see signs and treatment of hypoglycemia above Low potassium blood levels, fast heart rate, fatigue, headache, hunger. Chest pain or palpitations, persistent fatigue, confusion, numbness of mouth, lips, or tongue, muscle weakness or tremors, vision changes, flu-like symptoms Swelling, itching, redness, warmth, or pain at the injection site.

Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Save this study.

Warning You have reached the maximum number of saved studies Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. Federal Government. Read our disclaimer for details. Last Update Posted : April 18, Study Description.

Detailed Description:. The planned duration of enrollment is 6 months. The study consists of 2 weeks screening phase and a study period that was planned to be 24 weeks. FDA Resources. Arms and Interventions. Outcome Measures. Eligibility Criteria. Inclusion Criteria: Patients must have given their signed informed consent. Males or females between 18 and 79 years of age. Diagnosis of type 2 diabetes mellitus for at least one year. Ability and willingness to perform SMBG profiles using a plasma glucose meter at least twice a day.

Patients must be able to understand and willing to adhere to and be compliant with the study protocol Exclusion Criteria: Patients, who have had stroke, MI, coronary artery bypass graft CABG , percutaneous transluminal coronary angioplasty PTCA or angina pectoris within the last 12 months. Patients with congestive heart failure requiring pharmacological treatment. Patients on non-selective beta blockers including ocular.

Patients with acute infections. Patients with diagnosis of dementia. Treatment with systemic steroids or large doses of inhaled steroids. Patients with acute or chronic metabolic acidosis, including diabetic ketoacidosis. Patients with planned radiological examinations requiring administration of contrasting agents. Clinical evidence of active liver disease, or serum ALT 2. Patients with history of hypoglycemia unawareness. Pregnant or lactating females.